Catastrophic Antiphospholipid Syndrome: A Review

7Citations
Citations of this article
128Readers
Mendeley users who have this article in their library.

Abstract

Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by thrombotic or obstetric events occurring in individuals who have persistent antiphospholipid antibodies. Catastrophic antiphospholipid syndrome (CAPS) is a rare and potentially fatal form of APS characterized by severe thrombotic complications occurring in multiple organs over a short period of time or simultaneously. CAPS is associated with a high (50%) death rate. Infections, multi-organ failure, and cerebral and heart thrombosis represent the main complications of this syndrome. Generally, anticoagulants, glucocorticoids, therapeutic plasmapheresis (TPE), and intravenous immunoglobulin (IVIG) are used in combination for treatment. Multidisciplinary care involving different specialists from hematology, rheumatology, nephrology, infectious disease, critical care, and obstetrics is often required due to the complexity of the disease. Recent data emphasize the effectiveness of biologics such as anti-TNF-a monoclonal antibodies (adalimumab, certolizumab), anti-CD38 monoclonal antibody (daratumumab), BAFF/Blys inhibitor (belimumab), and BTK inhibitor (zanubrutinib) against CAPS. In order to understand the underlying causes of CAPS, one future possibility involves investigating and characterizing the hereditary and acquired risk factors associated with CAPS.

References Powered by Scopus

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

5984Citations
N/AReaders
Get full text

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International Workshop

2549Citations
N/AReaders
Get full text

Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

1841Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Cutting-Edge Techniques and Drugs for the Treatment of Pulmonary Embolism: Current Knowledge and Future Perspectives

5Citations
N/AReaders
Get full text

Emergencies in inflammatory rheumatic diseases

3Citations
N/AReaders
Get full text

Catastrophic Thrombosis: A Narrative Review

2Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Siniscalchi, C., Basaglia, M., Riva, M., Meschi, M., Meschi, T., Castaldo, G., & Di Micco, P. (2024, March 1). Catastrophic Antiphospholipid Syndrome: A Review. Immuno. Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/immuno4010001

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 36

54%

Researcher 16

24%

Professor / Associate Prof. 14

21%

Lecturer / Post doc 1

1%

Readers' Discipline

Tooltip

Medicine and Dentistry 76

86%

Agricultural and Biological Sciences 5

6%

Biochemistry, Genetics and Molecular Bi... 5

6%

Pharmacology, Toxicology and Pharmaceut... 2

2%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free